Adriaan Moelker
Chief Executive Officer (CEO)
- Year of birth: 1964
- Nationality: Dutch
- Appointment: since February 2020, appointed until January 2027
Adriaan Moelker is an experienced manager of global, innovation-oriented companies. Before joining BRAIN Biotech AG, he held a number of management positions in the biotechnology sector during his 30-year career. At Darmstadt-based AB Enzymes GmbH, he served as Managing Director for nine years, during which time he led the company to double-digit profit growth while building a strong business development pipeline. Prior to that, Adriaan Moelker spent twelve years at Genencor (now DuPont) and DSM in the enzymes business, always focusing on business and innovation management. As a result, he has extensive global experience in all major industrial enzyme segments: Food, Feed and Technology. For the last six years, he led a printing solutions business for the Flint Group, where he implemented major strategic changes and accelerated the innovation pipeline.
Adriaan Moelker holds a Master of Business Administration (MBA) and a Bachelor's degree from the University of Nyenrode (Netherlands). He has also completed executive education modules at INSEAD, Fontainebleau (France) and Harvard Business School, Boston (USA).
Adriaan Moelker has been appointed Chairman of the Management Board of BRAIN Biotech AG with effect from February 1, 2020 and until January 2027.